IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION

The presently disclosed subject matter provides compositions, kits, and methods comprising imaging agents that can detect Programmed Cell Death Ligand 1 (PD-L1). The presently disclosed imaging agents can be used to detect diseases and disorders, such as cancer, infection, and inflammation, in a sub...

Full description

Saved in:
Bibliographic Details
Main Authors KUMAR, Dhiraj, NIMMAGADDA, Sridhar, POMPER, Martin Gilbert
Format Patent
LanguageEnglish
French
Published 10.02.2022
Online AccessGet full text

Cover

More Information
Summary:The presently disclosed subject matter provides compositions, kits, and methods comprising imaging agents that can detect Programmed Cell Death Ligand 1 (PD-L1). The presently disclosed imaging agents can be used to detect diseases and disorders, such as cancer, infection, and inflammation, in a subject. La présente invention concerne des compositions, des kits et des procédés comprenant des agents d'imagerie qui peuvent détecter un ligand de mort cellulaire programmée 1 (PD-L1). Les agents d'imagerie décrits peuvent être utilisés pour détecter des maladies et des troubles, tels que le cancer, l'infection et l'inflammation, chez un sujet.
Bibliography:Application Number: WO2021US44951